BFEC
MRNA icon

Benjamin F. Edwards & Company’s Moderna MRNA Stock Holding History

Benjamin F. Edwards & Company’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$634K Buy
5,343
+3,998
+297% +$506K 0.01% 635
2024
Q1 		$144K Sell
1,345
-416
-24% -$41.9K ﹤0.01% 1001
2023
Q4 		$175K Buy
1,761
+258
+17% +$21.7K ﹤0.01% 912
2023
Q3 		$155K Buy
1,503
+89
+6% +$9.93K 0.01% 796
2023
Q2 		$172K Buy
1,414
+87
+7% +$11.6K 0.01% 775
2023
Q1 		$204K Sell
1,327
-968
-42% -$160K 0.01% 713
2022
Q4 		$412K Buy
2,295
+992
+76% +$162K 0.02% 516
2022
Q3 		$154K Buy
1,303
+978
+301% +$148K 0.01% 743
2022
Q2 		$46K Hold
325
– – ﹤0.01% 1059
2022
Q1 		$56K Buy
325
+168
+107% +$28.3K ﹤0.01% 995
2021
Q4 		$40K Sell
157
-6,541
-98% -$1.91M ﹤0.01% 1097
2021
Q3 		$2.58M Buy
6,698
+4,853
+263% +$1.79M 0.13% 166
2021
Q2 		$434K Buy
1,845
+884
+92% +$158K 0.02% 475
2021
Q1 		$126K Sell
961
-655
-41% -$94.9K 0.01% 787
2020
Q4 		$169K Buy
1,616
+1,416
+708% +$143K 0.01% 687
2020
Q3 		$14K Buy
200
+100
+100% +$6.97K ﹤0.01% 1193
2020
Q2 		$6K Sell
100
-240
-71% -$13.1K ﹤0.01% 1388
2020
Q1 		$10K Buy
+340
New +$7.82K ﹤0.01% 1252
2019
Q4 		– Sell
-600
Closed -$10K – 1922
2019
Q3 		$10K Hold
600
– – ﹤0.01% 1400
2019
Q2 		$9K Buy
600
+300
+100% +$6.44K ﹤0.01% 1453
2019
Q1 		$6K Hold
300
– – ﹤0.01% 1447
2018
Q4 		$5K Buy
+300
New +$4.93K ﹤0.01% 1466

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Benjamin F. Edwards & Company's MRNA Position: Q2 2024 in Review

Benjamin F. Edwards & Company increased its Moderna (MRNA) stake by 297% in Q2 2024, buying an estimated $506K and bringing the position to 5,343 shares worth $634K. The position accounts for 0.01% of the portfolio, ranked #635.

Benjamin F. Edwards & Company first reported a position in MRNA in Q4 2018 and has held it in 22 quarters since. The position peaked at $2.58M in Q3 2021. 955 funds tracked by Wall St. Rank hold MRNA as of Q2 2024.

  • Benjamin F. Edwards & Company held 5,343 shares of Moderna worth $634K as of Q2 2024.
  • Benjamin F. Edwards & Company bought 3,998 Moderna shares in Q2 2024, an estimated $506K.
  • Moderna made up 0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #635 holding.
  • Benjamin F. Edwards & Company first reported a position in Moderna in Q4 2018 and has held it in 22 quarters since.
  • Benjamin F. Edwards & Company's Moderna position peaked at $2.58M in Q3 2021.
  • 955 funds tracked by Wall St. Rank held Moderna as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.